Interiglin 0.75mg/ml Infusion
Prescription Required
Product introduction
Interiglin 0.75mg/ml Infusion is a blood thinner which prevents formation of harmful blood clots. It is used in the treatment of a heart attack and also prevents the clotting of blood in the heart during an angioplasty (procedure to improve blood flow to the heart).
Interiglin 0.75mg/ml Infusion is administered under the supervision of a doctor. Your doctor will decide the dose and duration of the medicine for you. You should continue all your other medicines that are advised by the doctor for your long-term treatment even after this injection.
Use of this medicine may cause low blood platelets and increase your risk of bleeding. Let your doctor know immediately if you see pinpoint rash or blood in your vomits, urine, or stool. It may also cause low blood pressure as a side effect. Your doctor will explain the benefits and risks associated with this medicine before it is administered.
This medicine is used with caution for some people. Before taking it, you must inform the doctor if you are suffering from any bleeding disorder, kidney or liver disease. Also, let your doctor know if you are pregnant or breastfeeding and about all the other medications that you are taking regularly.
Interiglin 0.75mg/ml Infusion is administered under the supervision of a doctor. Your doctor will decide the dose and duration of the medicine for you. You should continue all your other medicines that are advised by the doctor for your long-term treatment even after this injection.
Use of this medicine may cause low blood platelets and increase your risk of bleeding. Let your doctor know immediately if you see pinpoint rash or blood in your vomits, urine, or stool. It may also cause low blood pressure as a side effect. Your doctor will explain the benefits and risks associated with this medicine before it is administered.
This medicine is used with caution for some people. Before taking it, you must inform the doctor if you are suffering from any bleeding disorder, kidney or liver disease. Also, let your doctor know if you are pregnant or breastfeeding and about all the other medications that you are taking regularly.
Uses of Interiglin Infusion
- Unstable angina
- Prevention of Blood clots
- Prevention of Heart attack
Benefits of Interiglin Infusion
In Prevention of Blood clots
Interiglin 0.75mg/ml Infusion prevents new blood clots from forming and prevents the existing ones from getting bigger. It works by blocking a substance in the body which is involved in blood clotting. Thus it helps your blood flow smoothly throughout the body. This can help reduce damage caused by clots in your lungs (pulmonary embolism), brain (stroke), heart (heart attack) or other blood vessels (thrombosis).
In Prevention of Heart attack
It prevents blood from clotting inside the veins and arteries. This helps the blood flow freely around your body thereby preventing a heart attack or stroke (or deep vein thrombosis or pulmonary embolism). Follow your doctor’s instructions carefully and make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine.
Side effects of Interiglin Infusion
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Interiglin
- Bleeding
- Decreased blood pressure
How to use Interiglin Infusion
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
How Interiglin Infusion works
Interiglin 0.75mg/ml Infusion is an antiplatelet medication. It works by preventing the platelets from sticking together, thereby decreasing the formation of harmful blood clots.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Interiglin 0.75mg/ml Infusion. Please consult your doctor.
Pregnancy
SAFE IF PRESCRIBED
Interiglin 0.75mg/ml Infusion is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding
CAUTION
Interiglin 0.75mg/ml Infusion should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Driving
NOT RELEVANT
Not relevant, as Interiglin 0.75mg/ml Infusion is intended for use in hospitalised patients.
Kidney
CAUTION
Interiglin 0.75mg/ml Infusion should be used with caution in patients with kidney disease. Dose adjustment of Interiglin 0.75mg/ml Infusion may be needed. Please consult your doctor.
Use of Interiglin 0.75mg/ml Infusion is not recommended in patients with severe kidney disease.
Use of Interiglin 0.75mg/ml Infusion is not recommended in patients with severe kidney disease.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Interiglin 0.75mg/ml Infusion in patients with liver disease. Please consult your doctor.
Use of Interiglin 0.75mg/ml Infusion is not recommended in patients with severe liver disease.
Use of Interiglin 0.75mg/ml Infusion is not recommended in patients with severe liver disease.
What if you forget to take Interiglin Infusion?
If you miss a dose of Interiglin 0.75mg/ml Infusion, please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Interiglin 0.75mg/ml Infusion
₹107.36/ml of Infusion
Eptiba Infusion
Intas Pharmaceuticals Ltd
₹84.02/ml of infusion
22% cheaper
₹133.94/ml of infusion
25% costlier
Intiflo 0.75mg/ml Infusion
Cipla Ltd
₹86.43/ml of infusion
19% cheaper
Eptiflo 0.75mg/ml Infusion
Sun Pharmaceutical Industries Ltd
₹82.75/ml of infusion
23% cheaper
Integrilin Injection
Merck Ltd
₹101.78/ml of infusion
5% cheaper
Quick tips
- It is usually given by your nurse or doctor as an infusion (drip) into a vein.
- It increases your risk of bleeding. Be careful while shaving, cutting fingernails or toenails or using sharp objects.
- Notify your doctor if you see blood in your vomit, urine or stool (black, tarry stools or bright red blood).
Fact Box
Chemical Class
Amino acids, Peptides analogues
Habit Forming
No
Therapeutic Class
BLOOD RELATED
Action Class
Glycoprotein IIb/IIIa Inhibitors
Patient concerns
FAQs
Can the use of Interiglin 0.75mg/ml Infusion increase the risk of bleeding?
Yes, Interiglin 0.75mg/ml Infusion increases the risk of bleeding. Always be careful while doing activities that may cause an injury or bleeding. Tell your doctor immediately if you notice any abnormal bruising or bleeding.
What medicines should I avoid while taking Interiglin 0.75mg/ml Infusion?
Interiglin 0.75mg/ml Infusion can interact with several medicines. Do not take any medicine without talking to your doctor.
When will I feel better after taking Interiglin 0.75mg/ml Infusion?
Interiglin 0.75mg/ml Infusion reduces your risk of developing blood clots in the blood vessels of your leg, lungs, heart and brain. You may not feel any difference after taking Interiglin 0.75mg/ml Infusion. However, keep taking this medicine as prescribed by your doctor because you will still be getting its full benefits.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 871.
- Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 355-56.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 485-46.
- Eptifibatide. Ferentino, Italy: Patheon Italia S.p.A.; 1998 [revised Mar. 2013]. [Accessed 18 Mar. 2019] (online) Available from:
- Drugs.com. Eptifibatide Pregnancy and Breastfeeding Warnings. [Accessed 18 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). Eptifibatide. [Accessed 18 Mar. 2019] (online) Available from:
Marketer details
Name: MSD Pharmaceuticals Pvt Ltd
Address: Platina, 8th Floor, C.59, G Block, Bandra Kurla Complex, Bandra (East) , Mumbai - 400098,
Country of origin: India
Lab tests offered by us
Related/Popular tests
NOT FOR SALE
We do not facilitate sale of this product at present
